HOXA5 and neoplasm: In the univariable analysis, clinical parameters such as age (OR = 0.98, 95% CI: 0.93–1.03, p = 0.329), tumor size (OR = 0.94, 95% CI: 0.80–1.11, p = 0.450), and stage (stage II vs. I: OR = 1.30, p = 0.774; stage III vs. I: OR = 0.65, p = 0.566) were not significantly associated with HOXA5 expression.